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Abstract
Wnt/b-catenin signalling pathway plays important roles in embryonic development and carcinogenesis. Overactivation of
the pathway is one of the most common driving forces in major cancers such as colorectal and breast cancers. The
downstream effectors of the pathway and its regulation of carcinogenesis and metastasis are still not very well understood.
In this study, which was based on two genome-wide transcriptomics screens, we identify MENA (ENAH, Mammalian enabled
homologue) as a novel transcriptional target of the Wnt/b-catenin signalling pathway. We show that the expression of
MENA is upregulated upon overexpression of degradation-resistant b-catenin. Promoters of all mammalian MENA
homologues contain putative binding sites for Tcf4 transcription factor – the primary effector of the Wnt/b-catenin pathway
and we demonstrate functionality of these Tcf4-binding sites using luciferase reporter assays and overexpression of b-
catenin, Tcf4 and dominant-negative Tcf4. In addition, lithium chloride-mediated inhibition of GSK3b also resulted in
increase in MENA mRNA levels. Chromatin immunoprecipitation showed direct interaction between b-catenin and MENA
promoter in Huh7 and HEK293 cells and also in mouse brain and liver tissues. Moreover, overexpression of Wnt1 and Wnt3a
ligands increased MENA mRNA levels. Additionally, knock-down of MENA ortholog in D. melanogaster eyeful and sensitized
eye cancer fly models resulted in increased tumor and metastasis formations. In summary, our study identifies MENA as
novel nexus for the Wnt/b-catenin and the Notch signalling cascades.
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Introduction
Wnt/b-catenin signalling pathway is critical for early and late
embryonic development [1,2] and it plays important roles during
tumorigenesis of various cancers [3]. b-catenin is a multifunctional
adaptor protein/transcription factor that is deregulated in many
cancers. In the absence of Wnt ligand, cytosolic b-catenin levels
are down-regulated via a degradation complex including CK1a,
GSK3b, Axin, APC, and PP2A in which processive phosphory-
lation of b-catenin by CK1a and GSK3b leads to its ubiquitina-
tion and proteasomal degradation. In the presence of Wnt ligand,
upon its binding to the frizzled/LRP5/6 receptor complex,
Dishevelled (Dsh/Dvl) is activated, at least in part by phosphor-
ylation. Activated Dsh is part of a protein complex that recruits
GSK3b away from the b-catenin degradation complex, allowing
the dephosphorylation and nuclear import of b-catenin, where it
activates the TCF/LEF family of transcriptional factors that
control expression of various genes related to cell cycle and
differentiation [4,5].
Wnt/b-catenin pathway is strongly implicated in breast
carcinogenesis, in addition to many other cancer types. Transgenic
mice expressing degradation-resistant b-catenin in mammary
gland tissue develop breast tumors [6,7]. According to immuno-
histochemical analysis, nuclear and cytoplasmic b-catenin levels
have been found to be elevated in about 60% of the breast tumors
[8,9]. Furthermore, reduced levels of extracellular Wnt-inhibitory
molecules sFRP1 and WIF1 have been linked to 80% and 60% of
breast carcinomas [10,11]. Additionally, b-catenin has been
associated with epidermal growth factor receptor (EGFR) family
members [12–16] and the stability of b-catenin and its TCF/LEF-
activating function has been suggested to be regulated via tyrosine
phosphorylation by the EGFR family [15,17–19], which may be
significant for breast carcinogenesis, since human epidermal
growth factor receptor 2 (HER2) is overexpressed in about 30%
of human breast tumors [20,21]. Hence, identification of novel
targets of Wnt/b-catenin pathway, serves an important purpose
for cancer research field, particularly breast cancer, since target
genes of the pathway are potential anti-cancer drug targets.
Many actin-associated proteins play important roles in carci-
nogenesis of various types of cancers [22]. MENA is an actin-
regulatory protein that belongs to ENA/VASP protein family
[23]. Members of this protein family are localized at the tips of
protruding lamellipodia and filopodia and adhesion foci; and they
are involved in control of cell motility and cell-cell adhesion, which
are important subjects for development of metastatic potential
[23]. Di Modugno et al. [24] showed that human MENA (hMENA)
is overexpressed in ,75% of primary breast cancers.
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of Gene Expression) and genome-wide microarray approaches to
screen for novel Wnt/b-catenin pathway targets by overexpressing
degradation-resistant S33Y-b-catenin [26] in Huh7 (hepatocellu-
lar carcinoma) cell lines, which lacks detectable nuclear endoge-
nous b-catenin levels [27]. In these screens we found MENA to be
differentially expressed and in this study we show that MENA is a
transcriptional target of the Wnt/b-catenin pathway.
Wnt and Notch pathways have essential roles in development
with well-studied crosstalks, yet their interplay in cancer is not well
understood. In order to investigate the role of MENA in
tumorigenesis, we tested whether knock-down of the Drosophila
homolog of MENA (Ena) can affect tumor formation in the D.
melanogaster eye cancer fly models ‘‘eyeful’’ and ‘‘sensitized’’. Eyeful
flies have a metastatic eye tumor phenotype induced by activated
Notch signalling due to overexpression of the Notch ligand Delta
and overexpression of polycomb genes lola and pipsqueak. Sensitized
flies overexpress only Delta and have an increased eye size
phenotype, but no metastatic tumors. Interestingly, we found that
Ena knock-down increases tumor formation and metastasis in both
fly models, indicating that Ena has a tumor suppressor role at a
crosstalk between the Wnt/b-catenin and the Notch signalling
cascades.
Results
Overexpression of b-catenin or Wnt ligands leads to
increase in mRNA levels of MENA and other actin-
associated proteins
This study stems from our previous work with Huh7 cells as a
hepatocellular carcinoma model, in which SAGE and genome-
wide microarray analysis were used to identify novel cancer
markers related to Wnt/b-catenin pathway. This pathway is
known to be relatively silent in Huh7 cells [27]. We generated
stable Huh7 cell line overexpressing degradation-resistant b-
catenin (S33Y mutation), as an approach to mimic activation of
the Wnt/b-catenin pathway. This stable cell line was used for
SAGE and microarray analyses. From these screens we found that
MENA expression was upregulated 5.5-fold upon overexpression
of the S33Y-b-catenin [25]. RT-PCR confirmed the microarray
data (Fig. 1). Stable and transient overexpression of S33Y-b-
catenin, as well as stimulation of the Wnt/b-catenin pathway by
overexpression of the Wnt1 or Wnt3a ligands, in an attempt to
stimulate the Wnt/b-catenin pathway through autocrine effect,
increased MENA mRNA levels.
TCF4-binding elements (TBEs) are well-conserved among
MENA ortholog promoter sequences
We analyzed the promoters of Homo sapiens, Macaca mulatta, Mus
musculus and Rattus norvegicus MENA ortholog genes using Tran-
scriptional Regulatory Element Database of Zhang Lab at CSHL
(http://rulai.cshl.edu) and found two putative TBEs in all four of
the promoters (Fig. 2A) with the exception of the mouse MENA
promoter, which has four putative TBEs. Importantly, human and
macaque TBEs proximal to the transcriptional start site (TSS)
differed by only 1 nucleotide and the second TBEs, which were
more distal to the TSS were identical (Fig. 2B). Also, the positions
of the human and the macaque TBEs with respect to the TSS
were found to be very similar. Equivocal sequence and position
similarity between the mouse and the rat TBEs was also observed.
All of the TBEs sequences matched the TCF4-binding consensus
sequence 59-WWCAAWG-39.
MENA promoter and b-catenin/TCF4 interact in vivo
To obtain further evidence for the interaction of MENA
promoter with the b-catenin/TCF4 complex in vivo, we performed
luciferase reporter assay utilizing the [21250…+1] MENA 59-
upstream fragment as the reporter expression-driving promoter
(Fig. 2C, 2D and 2E). We observed ,5-fold stimulation of MENA
promoter upon quadruple-mutant b-catenin overexpression in
Huh7 cells, which was suppressed by co-overexpression of
dominant-negative Tcf4 (DN-Tcf4) (Fig. 2C). In HeLa cells, the
effect of b-catenin overexpression could only be observed when co-
overexpressed with Tcf4 (Fig. 2D). Importantly, MENA promoter
activity was stimulated by ,6–9-fold upon overexpression of
recombinant Wnt1, Wnt3a, Wnt4 and Wnt5a ligands in Huh7
cells (Fig. 2E). In order to test the physiologic relevance of the
TBEs found in the MENA promoter, we performed chromatin
immunoprecipitation assay with monoclonal anti-b-catenin anti-
body using Huh7 and HEK293 cells and mouse brain and liver
tissues (Fig. 2F). PCR analysis of the DNA fragments immuno-
precipitated with this antibody showed that MENA promoter and
b-catenin/TCF4 complex interact in vivo in these cells and tissues.
Inhibition of b-catenin degradation via lithium treatment
leads to increased MENA mRNA level
Inhibition of GSK3b using LiCl is a widely-used approach to
mimic an activated Wnt/b-catenin pathway. We treated cells with
LiCl and observed the expected accumulation of endogenous b-
catenin to be concomitant with a significant increase in MENA
mRNA levels. In Huh7 cells, we performed a time-course of the
Figure 1. Overexpression of b-catenin-S33Y and Wnt ligans leads to increase in MENA transcription. (A) b-catenin-S33Y mutant was
stably overexpressed in Huh7 cells and MENA and Axin2 mRNA levels were analyzed using qRT-PCR. (B) b-catenin-S33Y was transiently overexpressed
(48 hrs) in U373 cells and MENA and b-catenin mRNA levels were compared using RT-PCR. (C) Wnt1 or Wnt3a ligans were overexpressed in Huh7 cells
(48 hrs) and MENA mRNA levels were compared using RT-PCR.
doi:10.1371/journal.pone.0037013.g001
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mRNA levels was observed after 24 hrs of LiCl-treatment. Huh7
cells entered senescence (data not shown) after 72 hrs of LiCl-
treatment, which can be the reason for the drop in the b-catenin
protein and MENA mRNA levels compared to the 48 hrs
timepoint. Treatment of U373, Sk-Mel-103 and Sk-Mel-19 cells
with LiCl for 24 hrs also lead to accumulation of endogenous b-
catenin and increase in MENA mRNA levels (Fig. 3D).
Figure 2. Promoters of mammalian MENA orthologs have functional Tcf4-binding elements (TBEs) that are regulated by the Wnt/b-
catenin pathway. (A) Schematic representation of the promoters and the identified putative TBEs. The location of the TBEs is indicated by boxes
and the sequences and locations with respect to transcriptional start sites (denoted by arrows) are shown under the boxes. Predicted binding motifs
for other transcription factors are also indicated. The length of the bar is 100 bp. The WWCAAWG sequence is the consensus sequence for TBEs. (B)
Alignment of proximal (TBE#1) and distal (TBE#2) TBE sequences. (C, D and E) Huh7 cells or HeLa cells were transfected with pGL3-MENA reporter
plasmid and the promoter activity was stimulated by co-transfecting degradation-resistant b-catenin, Tcf4 or Wnt ligans or inhibited by co-
transfecting dominant-negative Tcf4 (DNTcf4). The bars are given as averages (n=3) normalized to Renilla luciferase activity, which was used an
internal control. Error bars represent standard deviation (*=p,0.05, **=p,0.01 and ***=p,0.005, Student’s t-test). Each graph is a representative
of at least two independent experiments. ‘‘b-cat’’ denotes the quadruple-mutant b-catenin-4m (See Materials & Methods). (F) Chromatin
immunoprecipitation assay was done with monoclonal anti-b-catenin antibody and PCR (35–40 cycles) was used to detect MENA promoter
fragments. b-catenin was found to interact with MENA promoter in Huh7 and HEK293T cell context, as well as in mouse brain tissue and liver tissue
contexts. All experiments were repeated at least twice. An unrelated monoclonal antibody was used as the control IgG. The lower bands that appear
in the mouse brain gel image are the primer-dimer bands. The arrow indicates the band of the expected size.
doi:10.1371/journal.pone.0037013.g002
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formation
To examine the role of MENA in tumorigenesis, we investigated
whether downregulation of the Drosophila homolog of MENA
gene Ena affects tumor formation in fly eye cancer models. Knock-
down of axin in ‘‘eyeful’’ flies, which have high incidence of eye
tumor formation, resulted in an increased frequency (79%) of eyes
showing tumor formation and increased frequency (14%) of flies
showing metastasis, compared to eyeful flies expressing a negative
control RNAi (white gene) that showed only 42% of eyes with
tumor formation and 8% of flies with metastases (Fig. 4D and 4F).
Knock-down of Ena in eyeful flies resulted in 89% of tumor
prevelance and resulted in 17% of flies with metastases (Fig. 4D,
4F, 4H–I and 4L–M).
When this experiment was conducted in ‘‘sensitized’’ flies,
which have enlarged eyes, but no tumor formation, knock-down of
Ena induced de novo tumor formation in 17% of eyes and metastasis
formation in 4% of flies, compared to negative control (white gene)
which did not result in any tumor or metastasis formation (Fig. 4E,
4G, 4J–K and 4N–O). Axin knock-down in sensitized flies resulted
in comparable levels of tumor formation (16%) and metastasis
(3%).
Discussion
In this study, we have shown that MENA, a gene encoding an
actin-regulatory protein, is a transcriptional target of the Wnt/b-
catenin pathway. Overexpression of b-catenin and Wnt ligands
resulted in increased MENA transcription (Fig. 1). Using luciferase
reporter and chromatin immunoprecipitation assays, we con-
firmed that the putative TCF4-binding elements conserved among
mammalian homologues of MENA are indeed functional and are
regulated by the Wnt/b-catenin pathway (Fig. 2). Moreover,
GSK3b inhibition by lithium treatment showed that MENA
mRNA levels increase concurrently with the cytosolic accumula-
tion of b-catenin (Fig. 3).
It is noteworthy that MENA is a Wnt/b-catenin pathway target,
since MENA is overexpressed in ,75% of breast cancers and the
Wnt/b-catenin pathway is overactivated in many breast cancer
cell lines and tumors. Moreover, recently, MENA was found to be
overexpressed in colon cancer [28,29] and Wnt/b-catenin
pathway overactivation is one of the major causes of colon
carcinomas. This suggests that MENA could be one of the
downstream effectors of the Wnt/b-catenin pathway in these
cancers. Importantly, Wnt/b-catenin pathway is known to
regulate actin organization (e.g. via dishevelled) and formation of
filopodia (via regulation of RhoU) [30], while MENA also an
important component protruding filopodia.
Strikingly, in vivo MENA mRNA levels have been previously
shown to be upregulated in the brains of lithium-treated mice [31].
The same study showed that in vivo b-catenin levels are also
upregulated by this treatment. This is an important in vivo evidence
for MENA being a Wnt/b-catenin pathway target in brain, since
lithium-induced increased b-catenin levels lead to increase in
transcription of the pathway targets.
In addition to its supposed role in carcinogenesis, MENA is
known to be important in nervous system development, as MENA-
null mice display subtle deficiencies in forebrain commissure
formation [32]. Fascinatingly, Wnt pathways are known to
regulate commissure formation (reviewed in ref. [33]) at least
through Wnt4 and Wnt5.
In a recent genome-wide screen, MENA was found to be
associated with schizophrenia [34]. It is intriguing that Wnt1, Fz3
and GSK3b – major Wnt/b-catenin pathway signalling compo-
nents – have also been associated with schizophrenia or
susceptibility to schizophrenia [35–37]. Thus, MENA could be
Figure 3. Lithium-mediated inhibition of GSK3b leads to b-catenin accumulation and increase in MENA mRNA levels. (A) Western blot
analysis of Huh7 cells treated with either 25 mM NaCl or 25 mM LiCl for indicated timepoints. RT-PCR (B) and qRT-PCR (C) analysis of Huh7 cells
treated with either 25 mM NaCl or 25 mM LiCl for indicated timepoints. (D) RT-PCR analysis of U373, Sk-Mel-103 and Sk-Mel-19 cells treated with LiCl
for 24 hrs. Each image is a representative of at least two independent experiments.
doi:10.1371/journal.pone.0037013.g003
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which is associated with the pathogenesis of the disease.
It is exciting that MENA promoter was found to be associated
with b-catenin in a recent screen [38], where chromatin
immunoprecipitation coupled with massively parallel sequencing
(ChIP-Seq) was used to identify b-catenin binding regions in
HCT116 human colon cancer cells, suggesting that MENA is a
Wnt/b-catenin pathway target not only in liver and brain, but also
in colon cancer contexts.
The Wnt and Notch signalling pathways play important roles in
development and tumorigenesis and have reported crosstalks in
these processes, which are not well understood. These two
pathways have opposing effects during development. However,
in tumorigenesis, there are many examples where Wnt and Notch
pathways must be both activated to induce neoplasia, whereas
there are only a few examples where these pathways contradict.
For example, in epidermis, Notch1 is a tumour suppressor gene
that represses the Wnt/b-catenin pathway [39], while Wnt
signalling is known to promote epidermis neoplasia [40]. In this
study, we find MENA to be a Wnt/b-catenin pathway target and
show that it plays role in repressing Notch-mediated tumorigenesis
in eye cancer fly models – a novel example of how Wnt and Notch
pathways contradict in cancer. This is in contrast to the previously
reported role of MENA as a tumorigenesis-promoting protein –
MENA is overexpressed in ,75% of primary breast cancers and
has a role in activation of MAPK and Akt signalling [41,42]. The
discrepancy of our Drosophila results and the established
upregulation of Mena in cancer can be due to the following:
dysregulation of actin skeleton by Mena knock-down in eyeful and
sensitized flies may lead to increased metastasis and neoplasia due to
lack of proper cell attachment and increased cell motility, whereas
high levels of Mena in many human cancers could be due to the
fact that overexpression of Mena leads to overactivation of growth
factor signalling and therefore cells overexpressing Mena would be
predominant in certain tumors. In other words, artificially induced
lack of cytoskeleton-related function of Mena (knock-down in flies)
is promoting metastasis, whereas high levels of growth signalling-
related function of Mena (in human cancers) result in increased
proliferation and thus, increased neoplasia. Therefore, our
findings put MENA at a critical point of crosstalk between Wnt/
b-catenin and Notch pathways in regulating actin cytoskeleton and
provide a novel example of a Wnt target that represses Notch
signalling. Further studies are necessary to determine the role of
MENA at the crossroads of Wnt and Notch signalling pathways, in
the context of tumorigenesis and potentially brain development.
Materials and Methods
Cell Culture
All cell lines were obtained from American Tissue Culture
Collection (http://www.atcc.org) and maintained in Dulbecco’s
modified Eagle’s medium (Gibco) supplemented with 10% fetal
bovine serum (Gibco) at 37uCi n5 %C O 2. Passages 6–15 were
used for the experiments.
Plasmids
59-upstream fragments of hMENA gene were amplified from
human genomic DNA using the following primers: ‘‘Forward’’:
[TAA GCT AGC GAA GTC ATC CCT ATA CCT AGT G]
and ‘‘Reverse’’: AAA AAG CTT CAT GGT GCC GGC GGC].
The PCR fragments were cloned into a Firefly luciferase reporter
vector pGL3-basic (Promega) via NheI and HindIII sites which
were designed into the forward and the reverse primers,
respectively. To characterize b-catenin/TCF4 activity of various
cell lines, pGL3-OT and pGL3-OF Firefly luciferase reporter
plasmids with wild-type and mutant TCF4 binding sequences,
respectively, were used [43]. pRL-TK (Promega), a Renilla
luciferase internal control vector, was used for normalization of
Firefly luciferase signals. CS2+/b-catenin-4m plasmid (quadruple-
mutant with S33A, S37A, T41A and S45A mutations) and
LNCX-Wnt1 and LNCX-Wnt3a plasmids were kind gifts of Prof.
Xi He, Children’s Hospital, Harvard Medical School (Boston,
MA, USA). pcDNA-myc-hTCF4 and pcDNA-myc-DN-hTCF4
were from Prof. Bert Vogelstein, Johns Hopkins Oncology Center
(Baltimore, MD, USA).
Transfection and Luciferase assays
0.5 mg (per well of 6-well plate) of either pcDNA3 or pcDNA3-
S33Y were transfected into Huh7 cells by using Lipofectamine
2000 reagent (Invitrogen), following the manufacturer’s instruc-
tions. (For luciferase assays, pGL3-OT, pGL3-OF and pRL-TK
were co-transfected). Cells were harvested at indicated time points
into 1X Triton-HEPES Lysis Buffer [1% Triton X-100, 25 mM
HEPES, pH 7.4, 15 mM MgSO4, 4 mM EGTA, 1 mM DTT]
and frozen at 280uC. Luciferase activities were measured using
Dual Glo
TM Luciferase Assay System (Promega), as per the
procedure provided by the manufacturer.
RNA Extraction and RT-PCR
Cells were harvested into 350 mL of Buffer RLT and frozen at
280uC at indicated time points. Total RNA was isolated using the
RNeasyH Mini Kit (Qiagen) according to the manufacturer’s
protocol. RNA was reverse transcribed using ImProm-II
TM
Reverse Transcription System (Promega) as per manufacturer’s
instructions RNA extraction was performed from 30 mg head
tissue of F1 generation flies using the Rneasy Mini Kit (Qiagen)
according to the manufacturer’s protocol. RNA samples were
reverse transcribed using the First Strand cDNA Synthesis Kit
(Fermentas) according to the manufacturer’s instructions and used
as template in RT-PCRs. For Drosophila experiments, total RNA
was isolated from head tissues of Drosophila fly lines. RT-PCR
was performed in a total volume of 25 ml containing 50 ng of
genomic DNA and 0.25 mM primers in the presence of 1.5 mM
MgCl2, 0.25 mM of each dNTP and 0.5 U Taq DNA polymerase
(Fermentase). The following PCR conditions were used: 5 min at
94uC; 25 cycles of 30 s at 94uC, 30 s at 57uC and 30 s at 72uC,
followed by a final extension of 5 min at 72uC. The amplified
PCR products were analyzed on a 1,5% agarose gel containing
Figure 4. Ena knock-down induces tumor formation and metastasis in vivo. Ena (A), white (B) and axin (C) knock-down was confirmed by RT-
PCR. Actin was used as an internal control. Significant increase of tumor formation (D and E) and metastasis (F and G) in eyeful (Eyf) (D, F) and
sensitized (St) (E, G) flies upon knock-down of ena and axin genes is observed, when white knock-down is used as a control. (* indicates p,0.05; ***
indicates p,0.001 as analyzed by the chi-square test). Representative images of tumor and metastasis formations in eyeful and sensitized flies upon
knock-down of Ena (H-O). (H and I) ey-GAL4, UAS-Dl, eyeful/+; UAS-EnaRNAi/+ (‘‘+’’: wild-type chromosome) flies showing tumors in the eye tissue.
Every fold in the eye tissue is counted as a single tumor. (J and K) ey-Gal4, UAS-Dl/+, UAS-EnaRNAi/+ flies with tumors in the eye. (L and M) ey-GAL4,
UAS-Dl, eyeful/+; UAS-EnaRNAi/+ flies showing metastasis on the abdomen and thorax. (N and O) ey-Gal4, UAS-Dl/+, UAS-EnaRNAi/+ flies with
metastasis on the back and abdomen.
doi:10.1371/journal.pone.0037013.g004
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previously [25].
Lithium treatment
Cells were seeded into 6-well plates and at ,80% confluence,
lithium acetate was added to a final concentration of 25 mM. Cells
were harvested at indicated timepoints by adding 350 mL of RLT
lysis buffer RNeasyH Mini Kit (Qiagen) and total RNA was
isolated using the RNeasyH Mini Kit (Qiagen) according to the
manufacturer’s protocol. For Western Blotting analysis, the above
procedure was repeated, but the cells were harvested at indicated
timepoints by adding 700 mL of 1X Triton-HEPES Lysis Buffer
[1% Triton X-100, 25 mM HEPES, pH 7.4, 15 mM MgSO4,
4 mM EGTA, 1 mM DTT]. The samples were passed through
syringe needle (23G) and analyzed by Bradford assay for total
protein levels. Equal protein amounts (100 mg) were resolved on
10% SDS-PAGE and analyzed by Western Blotting using
monoclonal anti-b-catenin antibody 9E10 (a gift by M. Ozturk,
Bilkent University, Ankara, Turkey) and anti-a-actin polyclonal
antibody (Cell Signalling Biotech.).
Chromatin ImmunoPrecipitation
The procedure was adapted from a previously published
protocol [25]. Cells in 150 mm plates were crosslinked by adding
0.8 ml of 37% formaldehyde into 20 ml medium and incubating
at 25uC for 15 min. To quench the crosslinking, 1.1 ml of 2.5 M
glycine were added and incubated at 25uC for 5 min. Cells were
harvested by scraping and centrifuged at 10006g for 5 min at
4uC. The cell pellet was washed 2 times with 10 ml ice-cold
PBS+1 mM PMSF. The cell pellet was resuspended in 2.5 ml of
ice-cold IP buffer (150 mM NaCl, 5 mM EDTA, 1% Triton X-
100, 0.5% NP-40, 50 mM Tris-HCl (pH 7.5) and 0.5 mM DTT)
containing protease inhibitor cocktail (Sigma) and an extra 1 mM
of PMSF. The cells were sonicated three times for 30 seconds at
power setting 5 with 50% power efficiency. The debris was
removed by centrifugation at 140006g for 10 min at 4uC. 100 ml
of the supernatant was saved as ‘‘input’’. The rest of the
supernatant was pre-cleared by incubating with 75 mL of 50%
slurry of Protein A-agarose plus Salmon Sperm DNA (33 mg/ml)
for 30 min at 4uC. The supernatant was incubated with anti-b-
catenin monoclonal antibody (9E10) or a control antibody (Goat
Anti-Rabbit/HRP) at 0.1 mg/ml concentration, overnight at 4uC.
Then, 30 mL of Protein A-agarose beads were added and
incubated at 4uC for 1.5 hours with gentle agitation. The beads
then were washed with 1 ml of the following buffers for 5 min at
4uC: (1) Low Salt Buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl); (2) High Salt
Buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-
HCl, pH 8.1, 500 mM NaCl); (3) TE Buffer (10 mM Tris-HCl,
1 mM EDTA, pH 8.0). DNA was eluted twice by adding 250 mL
of Elution Buffer (1% SDS and 0.1 M NaHCO3) and incubating
at 25uC for 15 min with frequent vortexing. The two 250 mL
elutions were then combined, 20 mL of 5 M NaCl was added and
incubated at 65uC for 4 hours to reverse the crosslinking. Next,
10 mL of 0.5 M EDTA, 20 mL of 1 M Tris-HCl, pH 6.5 and 2 mL
of 10 mg/ml proteinase K were added and the mixture was
incubated for 1 hr at 45uC. DNA was extracted with traditional
phenol-chloroform-isoamyl alcohol extraction and precipitated
with ethanol. The DNA pellet was resuspended in 50 mLo f
10 mM Tris-HCl, pH 7.4. PCR was done using a primer pair
amplifying 2620…+1 region of the hMENA promoter at the
following final concentrations of reactants and cycling conditions:
MgCl2 (2 mM), dNTP (0.5 mM), DMSO (5%), Taq DNA
polymerase (Fermentas) (0.04 u/mL); 92uC 5 min, 40 cycles
[92uC 30 sec, 55uC 1 min, 70uC 2 min], 70uC 5 min; Hot-start
at 92uC.
Drosophila Lines
Fly strains used were ‘‘ey-GAL4, GS88A8, UAS-Dl/Cyo’’
(eyeful flies), ‘‘ey-GAL4, UAS-Dl/Cyo’’ (sensitized flies), ‘‘UAS-
whiteRNAi’’ (kind gifts from Bassem Hassan), ‘‘UAS-AxinRNAi’’,
‘‘UAS-EnaRNAi’’ (obtained from Vienna Drosophila RNAi
Center). All flies were raised at 18uC and all crosses were stocked
at 25uC on standard fly food. Eye specific promoter eyeless was
used to drive Ena RNAi expression. The eyeful flies with the
downregulated Ena expression were selected from F1 generation
using specific balancer markers in order to analyze the tumor and
metastasis prevalence. As a negative control, white gene was
knocked-down and as a positive control, Axin was knocked-down.
To analyze the tumor prevalence, 180 flies were examined and
each eye was scored separately. Eyes were counted as tumorous
when the eye showed at least one fold, and metastasis could be
seen as masses of amorphous red-pigmented cells outside of the
eye field.
Mouse work
C57BL/6 mice were used in this study, which was approved by
the Bogazici University Ethics Committee. Mice were culled by
cervical dislocation and tissues were frozen in liquid nitrogen until
further use. For ChIP experiments, procedure described in the
‘‘Chromatin ImmunoPrecipitation’’ section was applied to the
brain and liver tissues.
In silico analysis and statistics
Promoter sequences were analyzed using Transcriptional
Regulatory Element Database located at Cold Spring Harbor
Laboratory website (http://rulai.cshl.edu/cgi-bin/TRED/tred.
cgi?process=home) and TFexplorer (http://www.tfexplorer.org)
[44]. First 2000 bp upstream of predicted transcriptional start site
were analyzed. Each experiment was performed at least twice. All
data are shown as means. Error bars represent standard
deviations. Statistical significances were tested by Student’s t-test.
P-values less than 0.05 were considered significant (one stars) and
p-values less than 0.005 were considered very significant (two
stars).
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